Constrictive Mycobacterium Tuberculosis Pericarditis, an increasingly common rare disease

Héctor Hugo Escutia Cuevas; Roberto Domínguez López; Julio Fernando Zaballa Contreras; Rosa Rebeca Vargas Ramón; Lizzeth Campuzano Pineda; Diego Jiménez Guarneros

2016, Number 1

<< Back Next >>

Rev Med UV 2016; 16 (1)

Constrictive Mycobacterium Tuberculosis Pericarditis, an increasingly common rare disease

Escutia CHH, Domínguez LR, Zaballa CJF, Vargas RRR, Campuzano PL, Jiménez GD

Full text

How to cite this article

Language: Spanish
References: 26
Page: 45-58
PDF size: 420.64 Kb.

ABSTRACT

Tuberculous pericarditis occurs in 1-2 percent of patients with pulmonary tuberculosis (TBP). Pericardial tuberculosis accounts for approximately 4% of acute pericarditis, 7% of cases of cardiac tamponade and 6% of cases of constrictive pericarditis, although its incidence may be much higher in populations with high prevalence of tuberculosis. It is known that 50% of patients with tuberculosis spills are not infected with HIV. It is a prevalent disease in endemic areas as the state of Veracruz, and not fully diagnosed in the past with the new diagnostic tools and the knowledge of it has become increasingly common, a phenomenon that affects prognosis of patients in the medium and long term.

REFERENCES

Adler, Y., Charron, P., Imazio, M., Badano, L., Bogaert, J. y Brucato, A. (2015). Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Revista Española de Cardiología. 68(12), 1126, e1-e46.
Aguilar, J., Summerson, C., González, M., López-Corvala, J., Jiménez, R. y Granda, M. (2007). Pericarditis Tuberculosa. Experiencia de 10 años. Archivos de Cardiología de México. 77, 209-16.
Arceo, A., Harrison, C., Sánchez, F., Domínguez, L. y Arredondo, V. (2015). Pericarditis efusivo-constrictiva: revisión a propósito de un caso. Revista Mexicana de Cardiología. 26(3), 102-10.
Center of Diseases Control and Prevention. (2003). Treatment of tuberculosis. MMWR Recommendations. Infectious Diseases Society of America. 52, 1.
Cho, Y., Schaff, H., Dearani, J., Daly, R., Park, S. y Li, Z. (2012). Completion pericardiectomy for recurrent constrictive pericarditis: importance of timing of recurrence on late clinical outcome of operation. Annals of Thoracic Surgery. 93, 1236–41.
Fowler, N. (1991). Tuberculous pericarditis. Journal of the American Medical Association. 266, 99-103.
Imazio, M., Mayosi, B., Brucato, A., Markel, G., Trinchero, R., Spodick, D. et al. (2010). Triage and management of pericardial effusion. Journal of Cardiovascular Medicine. Hagerstown Md. 11, 928–35.
Imazio, M., Spodick, D., Brucato, A., Trinchero, R. y Adler, Y. (2011). Controversial issues in the management of pericardial diseases. Circulation. 121, 916–28.
Imazio, M. (2012). Contemporary management of pericardial diseases. Current Opinion in Cardiology. 27, 308–17.
Imazio, M. y Adler, Y. (2013). Management of pericardial effusion. European Heart Journal. 34, 1186–97.
Imazio, M. y Gaita, F. (2015). Diagnosis and treatment of pericarditis. Heart., 101, 1159–68.
Komsuoğlu, B., Göldelï, O., Kulan, K. y Komsuoğlu, S. (1995). The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. European Heart Journal. 16, 1120-6.
Larrieu, A., Tyers, F., Williams, E. y Derrick, J. (1980). Recent experience with tuberculous pericarditis. Annals of Thoracic Surgery. 29, 460-4.
Legorreta, A., Niño, S., Saldaña, Y., Chavarría, P., Domínguez, R., Barrientos, E. et al. (2012). Pericarditis tuberculosa en paciente con VIH, reporte de un caso y revisión de la literatura. Enfermedades Infecciosas y Microbiología Clínica. 32(1), 31-6.
Mayosi, B., Burgess, L. y Doubell, A. (2005). Tuberculous Pericarditis. Circulation. 112, 3608-16.
Mayosi, B., Ntsekhe, M. y Bosch, J. (2014). Prednisolone and Mycobacterium indicuspranii in tuberculous pericarditis. New England Journal of Medicine. 371, 1114-21.
Oliver, C., Marín, F., Pineda, J., Lujan, J., García, A. y Climent, V. (2002). ¿Debemos pensar en una etiología específica en pacientes con taponamiento cardíaco? Revista Española de Cardiología. 55, 493-8.
Pandie, S., Peter, J., Kerbelker, Z., Meldau, R., Theron, G., Govender, U. et al. (2014). Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study. BMC Medicine. 12, 101.
Peter, J., Richard, N., Denkinger, C. y Madhukar, P. (2012). Diagnosis of TB: state of the art. European Respiratory Monograph. 58, 124–43.
Reuter, H., Burgess, L. y Doubell, A. (2005). Role of chest radiography in diagnosing patients with tuberculous pericarditis. Cardiovascular Journal of South Africa. 16, 100-8.
Sagristà-Sauleda, J., Permanyer, G. y Soler, J. (1988). Tuberculous pericarditis: ten-year experience with a prospective protocol for diagnosis and treatment. Journal of American College of Cardiology. 11, 720-4.
Sagristà-Sauleda, J., Mercé, J., Permanyer, G. y Soler, J. (2000). Clinical clues to the causes of large pericardial effusions. Journal of the American Medical Association. 109, 90-5.
Sagristà-Sauleda, J., Ángel, J. y Sánchez, A. (2004). Effusive-constrictive pericarditis. New England Journal of Medicine. 350, 460-9.
Secretaría de Gobernación de México. CONAPO. (2012). Indicadores demográficos básicos 1990-2012. En línea. Consultado el 21 de octubre de 2014. Disponible en: http://www.conapo.gob.mx.
Secretaría de Salud de México. CENAPRECE. (Agosto 2013). Reporte final. Evaluación externa del programa de control de Tuberculosis de México. Consultado el 20 de octubre de 2014. En línea. Disponible en: http://www. cenaprece.salud.gob.mx/programas/interior/micobacteriosis.
Zeka, A., Tasbakan, S. y Cavusoglu, C. (2011). Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. Journal of Clinical Microbiology. 49, 4138.